MINI REVIEW
Accepted on 17 Jul 2025
Mapping the clinical trial landscape of multiple primary lung cancer in the era of precision oncology:Persistent exclusion and design limitations hamper evidence-based treatment development
doi 10.3389/fonc.2025.1642062